ScholarWorks@Gyeongsang National University

Browsing by Kim, YireAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 4 of 4

SCIESCOPUS
Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case reportopen access

Kim, Yire; Kwak, Jihye; Jung, Sehyun; Lee, Seunghye; Jang, Ha Nee; Cho, Hyun Seop; Chang, Se-Ho; Kim, Hyun-Jung

ArticleIssue Date2021CitationWORLD JOURNAL OF CLINICAL CASES, v.9, no.21, pp 6130 - 6137PublisherBAISHIDENG PUBLISHING GROUP INC
SCIESCOPUSKCI
Population-Based Regional Cancer Incidence in Korea: Comparison between Urban and Rural Areasopen access

Song, Haa-Na; Go, Se-Il; Lee, Won Sup; Kim, Yire; Choi, Hye Jung; Lee, Un Seok; Kang, Myoung Hee; Lee, Gyeong-Won; Kim, Hoon-Gu; Kang, Jung Hun, et al.

ArticleIssue Date2016CitationCANCER RESEARCH AND TREATMENT, v.48, no.2, pp 789 - 797PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneopen access

Go, Se-Il; Park, Mi Jung; Song, Haa-Na; Kim, Hoon-Gu; Kang, Myoung Hee; Lee, Hyang Rae; Kim, Yire; Kim, Rock Bum; Lee, Soon Il; Lee, Gyeong-Won

ArticleIssue Date2016CitationJOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, v.7, no.5, pp 567 - 576PublisherWILEY
SCISCIESCOPUS
Rhabdomyolysis associated with single-dose intravenous esomeprazole administration A case reportopen access

Jeon, Dae-Hong; Kim, Yire; Kim, Min Jeong; Cho, Hyun Seop; Bae, Eun Jin; Chang, Se-Ho; Park, Dong Jun

ArticleIssue Date2016CitationMEDICINE, v.95, no.29PublisherLIPPINCOTT WILLIAMS & WILKINS
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어